{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Rupasinghe D"],"funding":["NIAID NIH HHS"],"pagination":["686-699"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11496006"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["31(11)"],"pubmed_abstract":["HCV RNA test determines current active infection and is a requirement prior to initiating HCV treatment. We investigated trends and factors associated with post-diagnosis HCV RNA testing rates prior to HCV treatment, and risk factors for first positive HCV RNA among people living with HIV (PLHIV) with HCV in the Asia-Pacific region. PLHIV with positive HCV antibody and in follow-up after 2010 were included. Patients were considered HCV-antibody positive if they ever tested positive for HCV antibody (HCVAb). Repeated measures Poisson regression model was used to analyse factors associated with post-diagnosis HCV RNA testing rates from positive HCVAb test. Factors associated with time to first positive HCV RNA from positive HCVAb test were analysed using Cox regression model. There were 767 "],"journal":["Journal of viral hepatitis"],"pubmed_title":["Post-Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia-Pacific Region."],"pmcid":["PMC11496006"],"funding_grant_id":["U01 AI069907"],"pubmed_authors":["Pujari S","Somia IKA","Pham TN","Rupasinghe D","Do CD","Choi JY","on behalf the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia‐Pacific","Ross J","Khol V","Lee MP","Kumarasamy N","Jiamsakul A","Avihingsanon A","Kiertiburanakul S"],"additional_accession":[]},"is_claimable":false,"name":"Post-Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia-Pacific Region.","description":"HCV RNA test determines current active infection and is a requirement prior to initiating HCV treatment. We investigated trends and factors associated with post-diagnosis HCV RNA testing rates prior to HCV treatment, and risk factors for first positive HCV RNA among people living with HIV (PLHIV) with HCV in the Asia-Pacific region. PLHIV with positive HCV antibody and in follow-up after 2010 were included. Patients were considered HCV-antibody positive if they ever tested positive for HCV antibody (HCVAb). Repeated measures Poisson regression model was used to analyse factors associated with post-diagnosis HCV RNA testing rates from positive HCVAb test. Factors associated with time to first positive HCV RNA from positive HCVAb test were analysed using Cox regression model. There were 767 ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-06-05T06:51:16.996Z","creation":"2026-05-13T14:29:01.504Z"},"accession":"S-EPMC11496006","cross_references":{"pubmed":["39115260"],"doi":["10.1111/jvh.13993"]}}